← Back
product
Daraxonrasib
Last discussed Oct 19, 2026
An investigational RAS inhibitor from Revolution Medicines (RMC-6236) that targets KRAS-driven cancers such as pancreatic cancer.
Recently discussed in
412 ‒ The evolving science of cancer: emerging approaches to prevention and early detection, & more
Siddhartha Mukherjee · Oct 19, 2026
What creators say
SM
Siddhartha Mukherjee
mentioned
Used for: Shutting off KRAS in pancreatic cancer
Praised: Extends life in patients with metastatic pancreatic cancer
vs: A small-molecule approach rather than CAR-T immunotherapy; has nasty skin sid...
"You've seen cases of pancreatic cancer treated with daraxonrasib, a new medicine against one of those killer genes called Ras. It's extended the life of patients."
More from Siddhartha Mukherjee →Keep exploring
Topics
About this data
- ✓45,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out
Get an email when a new creator recommends it